Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.

Pinkerton, Joann V

Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials. [electronic resource] - Journal of women's health (2002) Jan 2014 - 18-28 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1931-843X

10.1089/jwh.2013.4392 doi


Dose-Response Relationship, Drug
Double-Blind Method
Estrogens--administration & dosage
Estrogens, Conjugated (USP)--administration & dosage
Female
Health Status
Hot Flashes--drug therapy
Humans
Indoles--administration & dosage
Middle Aged
Postmenopause--drug effects
Quality of Life
Selective Estrogen Receptor Modulators--administration & dosage
Severity of Illness Index
Surveys and Questionnaires
Time Factors
Treatment Outcome